Page last updated: 2024-09-03

taraxasterol and Thyroid Neoplasms

taraxasterol has been researched along with Thyroid Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bai, Y; Han, P; Kou, B; Li, X; Liu, J; Wang, X; Xu, C; Yao, X; Zhang, S; Zhao, Q; Zheng, Z; Zhu, J1

Other Studies

1 other study(ies) available for taraxasterol and Thyroid Neoplasms

ArticleYear
Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling.
    Human & experimental toxicology, 2021, Volume: 40, Issue:12_suppl

    Topics: beta Catenin; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Protease Inhibitors; Sterols; Thyroid Cancer, Papillary; Thyroid Neoplasms; Transforming Growth Factor beta1; Triterpenes; Wnt Signaling Pathway

2021